Pharm Plan Agenda 2021.10.08: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
← Older edit
Michael tan (talk | contribs)
2,698 edits
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 3: Line 3:
== Welcome ==
== Welcome ==
* Participants
* Participants
** Introduction new members
** Hernany Silva Costa Melo ( Nictiz)
** Anne van Berkel Meier ( GS1)




Line 18: Line 21:
== Work items ==
== Work items ==


* Prescription FHIR profiles( see proposals Jose)
* Description of work items + Architecture diagram?
** Project lead: Jose
 
** Stakeholders: Belgium, Switzerland
* MPD FHIR profiles(see proposals Jose)
* Dispense FHIR profiles( see proposal Jose)
** Agree on the name of the profile
** These 2 proposals will be combined as one work item
** Discuss call schedule
** Project lead: Jose
** evaluate use cases and data models investigated so far
* Medication record (less urgent than the previous work item)
** Inclusion of other reference models? eHDSI, ISO 17253, 19293, NL ZIBs, etc -
** Project lead Jose
** Collaboration with ISO in the production of the LM
** Stakeholder: Belgium?
 
* Oncology medication management
* Vaccination (Project lead Juergen)
** Updates from Belgium
 
* Medication record (Project lead Jose)
 
* Oncology medication management (Project lead Juergen)
** A functional requirement is required. Preferably supported by a standard like IHE.
** A functional requirement is required. Preferably supported by a standard like IHE.
** Candidate work item depending on funding
** Candidate work item depending on funding
** Project lead Juergen
** Stakeholder: Vinzenz Gruppe Hospital Trust, Austria
** Stakeholder: Vinzenz Gruppe Hospital Trust, Austria
* Vaccination
 
** Candidate work item depending on funding
 
** Project lead Juergen
* Supply (Project lead: Jose)
** Stakeholder: Netherlands, Switzerland, WHO
** Will send an interim report and restart work
** other partners: PATH, US CDC, Gavi
 
* Supply
** Project lead Jose
** Stakeholder: PATH, Digital Square, GS1
== Any other business ==
== Any other business ==

Latest revision as of 07:31, 8 October 2021

Agenda

Welcome

  • Participants
    • Introduction new members
    • Hernany Silva Costa Melo ( Nictiz)
    • Anne van Berkel Meier ( GS1)


  • Review and Approve Agenda

Planning Schedule

* Outcome of Election procedures

Board Report

Review of the last board report

Work items

  • Description of work items + Architecture diagram?
  • MPD FHIR profiles(see proposals Jose)
    • Agree on the name of the profile
    • Discuss call schedule
    • evaluate use cases and data models investigated so far
    • Inclusion of other reference models? eHDSI, ISO 17253, 19293, NL ZIBs, etc -
    • Collaboration with ISO in the production of the LM
  • Vaccination (Project lead Juergen)
    • Updates from Belgium
  • Medication record (Project lead Jose)
  • Oncology medication management (Project lead Juergen)
    • A functional requirement is required. Preferably supported by a standard like IHE.
    • Candidate work item depending on funding
    • Stakeholder: Vinzenz Gruppe Hospital Trust, Austria


  • Supply (Project lead: Jose)
    • Will send an interim report and restart work

Any other business

Retrieved from "http://wiki.ihe.net/index.php?title=Pharm_Plan_Agenda_2021.10.08&oldid=126305"